title: [Patient education. Information letter on treatment of psoriasis with infliximab (Remicade)].
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000209:etiology; D006801:Humans; D007239:Infections / Q000209:etiology; D000069285:Infliximab; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab